News | Stent Grafts | February 14, 2019

Aortic Stent Graft Global Market to Reach $5.4 Billion by 2028

Abdominal aortic stent grafts will remain largest segment due to greater prevalence of abdominal aortic aneurysms

Aortic Stent Graft Global Market to Reach $5.4 Billion by 2028

February 14, 2019 — Abdominal aortic stent grafts will remain the largest segment in the global aortic stent graft market at least through 2028 due to the high prevalence of abdominal aortic aneurysms (AAA) relative to thoracic abdominal aneurysms (TAA), according to a new report from GlobalData. The abdominal segment will reach an estimated $2.8 billion global value by 2028, while the overall global aortic stent graft market is expected to reach $4.5 billion in the same period. This represents a compound annual growth rate of 5.4 percent between 2018 and 2028.

The company’s latest report, ‘Aortic Stent Grafts – Cardiovascular Market Analysis and Forecast Model’ reveals that Asia Pacific will be one of the fastest growing regions at a CAGR of 6.7 percent during the forecast period, with North America and Europe following closely behind at 4.9 percent and 4.6 percent, respectively.

David Brown, medical devices analyst at GlobalData commented, “Advances in stent graft design, such as with fenestrated and branched endografts, continue to expand the eligible patient pool for endovascular repair by addressing increasingly complex aneurysm anatomies.”

Although endovascular repair of aneurysms is a commonly used procedure and is increasingly employed over open repair procedures for the majority of aneurysms, barriers to market growth include the high cost of aortic stent graft devices and the relative lack of long-term outcome benefits versus open aortic repair.

For more information: www.globaldata.com


Related Content

News | Stent Grafts

April 26, 2023 — Medtronic today announced its Endurant abdominal aortic aneurysm (AAA) stent graft system continues to ...

Home April 26, 2023
Home
News | Stent Grafts

January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized ...

Home January 12, 2023
Home
News | Stent Grafts
May 4, 2022 – Seeking to bolster its development of a biocompatible graft that promises to reshape the future of cardiac ...
Home May 04, 2022
Home
News | Stent Grafts

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug ...

Home October 09, 2019
Home
News | Stent Grafts

October 8, 2019 — PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) ...

Home October 08, 2019
Home
News | Stent Grafts

July 10, 2019 — W. L. Gore & Associates Inc. (Gore) announced the first U.S. implant of the Gore Tag Conformable ...

Home July 10, 2019
Home
Technology | Stent Grafts

May 15, 2019 — W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted ...

Home May 15, 2019
Home
Technology | Stent Grafts

February 7, 2019 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for the Valiant ...

Home February 07, 2019
Home
News | Stent Grafts

January 7, 2019 — Endologix Inc. announced that in order to ensure optimal outcomes for patients, unrestricted sales and ...

Home January 07, 2019
Home
News | Stent Grafts

July 16, 2018 — Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented ...

Home July 16, 2018
Home
Subscribe Now